New eudravigilance

The New EudraVigilance Human System is now live!

The system was launched yesterday with enhanced features for the reporting and analysis of adverse reactions

The system was launched yesterday with enhanced features for the reporting and analysis of adverse reactions
November 23, 2017
Yesterday, 22nd November 2017, The European Medicines Agency (EMA) launched yesterday, a new and improved EudraVigilance system. EudraVigilance is  the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the European Economic Area (EEA). During this period, the electronic reporting of individual case safety reports (ICSRs) by NCAs, MAHs and sponsors will be disrupted, while the electronic submission of data on medicines (Article 57) will be unavailable.
The new system has enhanced features for the reporting and analysis of suspected adverse reactions to support a better safety monitoring of medicines and a more efficient reporting process for stakeholders. Expected benefits:
  • Simplified reporting of ICSRs and re-routing of ICSRs to Member States, as MAHs will no longer have to provide these reports to NCAs, but directly to EudraVigilance;
  • Better detection of new or changing safety issues;
  • Increased transparency based on broader access to reports of suspected adverse reactions via the portal.
  • Enhanced search and more efficient data analysis capabilities;
  • Increased system capacity and performance to support large volumes of users and reports;
  • More efficient collaboration with the World Health Organisation, as EMA will make the reports of individual cases of suspected adverse reactions within EEA available to WHO Uppsala Monitoring Centre Directly from Eudravigilance (Member States will not have to do this task anymore).
After the go-live of the new system, the old EudraVigilance continues working, however, it is restricted to functionalities related to extended EudraVigilance Medicinal Products Dictionary (xEVMPD) and the electronic data submission on medicines (Article 57).
The following important documents are now published on the Eudravigilance website, supporting of using the new sytem:
  • EVWEB release notes – new
  • EVWEB User Manual (updated)
  • EVDAS release notes for MAHs – new (published on the EVDAS welcome page)
  • EVDAS user manual for MAHs – new
  • XCOMP release notes (updated)
For the latest information, please visit the new EMA dedicated webpages:
  • EudraVigilance
 Contact us if you need further support at [email protected]

Search News & Events

  • Filter by category


Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting